Prevention and control of multidrug-resistant Gram-negative bacteria in adult intensive care units: A systematic review and network meta-analysis

Clinical Infectious Diseases

Volumn 64, Issue , 2017, Pages S51-S60

  Teerawattanapong, Nattawat ^a   Kengkla, Kirati ^b   Dilokthornsakul, Piyameth ^c   Saokaew, Surasak ^b,c,d   Apisarnthanarak, Anucha ^e   Chaiyakunapruk, Nathorn ^c,d,f,g  

^a Ubon Ratchathani University   (United States)

^b UNIVERSITY OF PHAYAO   (Thailand)

^c NARESUAN UNIVERSITY   (Thailand)

^d MONASH UNIVERSITY MALAYSIA   (Malaysia)

^e THAMMASAT UNIVERSITY   (Thailand)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Infection prevention and control; Intensive care units; Multidrug resistant gram negative bacteria

Indexed keywords

ACINETOBACTER BAUMANNII; APACHE; BACTERIAL COLONIZATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; META ANALYSIS; MORTALITY; MORTALITY RATE; NETWORK META-ANALYSIS; PREVENTION AND CONTROL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ADULT; CLINICAL TRIAL (TOPIC); CROSS INFECTION; DRUG EFFECTS; FEMALE; GRAM NEGATIVE INFECTION; INFECTION CONTROL; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PROCEDURES; PSEUDOMONAS AERUGINOSA; YOUNG ADULT;

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MIDDLE AGED; NETWORK META-ANALYSIS; PSEUDOMONAS AERUGINOSA; YOUNG ADULT;

EID: 85029946732     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix112     Document Type: Review

References (88)

1. Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance\-The need for global solutions. Lancet Infect Dis 2013; 13:1057-98
2. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8:159-66
3. Bertrand X, Dowzicky MJ. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Clin Ther 2012; 34:124-37
4. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-96
5. Zowawi HM, Harris PN, Roberts MJ, et al. The emerging threat of multidrug-resistant gram-negative bacteria in urology. Nat Rev Urol 2015; 12:570-84
6. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe. Euro Surveill 2008; 13
7. Karaiskos I, Giamarellou H. Multidrug-resistant and extensively drug-resistant gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother 2014; 15:1351-70
8. Ofner-Agostini M, Varia M, Johnston L, et al; Canadian Nosocomial Infection Surveillance Program. Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals. Am J Infect Control 2007; 35:563-8
9. Pogorzelska M, Stone PW, Larson EL. Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study. Am J Infect Control 2012; 40:696-700
10. Apisarnthanarak A, Khawcharoenporn T, Mundy LM. Practices to prevent multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in Thailand: a national survey. Am J Infect Control 2013; 41:416-21
11. Drees M, Pineles L, Harris AD, Morgan DJ. Variation in definitions and isolation procedures for multidrug-resistant gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network. Infect Control Hosp Epidemiol 2014; 35:362-6
12. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007; 35:S165-93
13. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35(10 suppl 2):S65-164
14. Tacconelli E, Cataldo MA, Dancer SJ, et al; European Society of Clinical Microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20(suppl 1):1-55
15. Yokoe DS, Anderson DJ, Berenholtz SM, et al; Society for Healthcare Epidemiology of America (SHEA). A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol 2014; 35:967-77
16. Centers for Disease Control and Prevention. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) 2015. Available at: http://www.cdc. gov/hai/pdfs/cre/cre-guidance-508.pdf. Accessed 24 August 2016
17. Petros AJ, Silvestri L, van Saene HK, et al. 2B or not 2B for selective decontamination of the digestive tract in the surviving sepsis campaign guidelines. Crit Care Med 2013; 41:385-6
18. Moodley P, Whitelaw A. The pros, cons, and unknowns of search and destroy for carbapenem-resistant Enterobacteriaceae. Curr Infect Dis Rep 2015; 17:483
19. Teerawattanapong N, Apisarnthanarak A, Kengkla K, Saokaew S, Dilokthornsakul P, Chaiyakunapruk N. Prevention and control of multidrug-resistant gram-negative bacteria in adult intensive care units: a systematic review and network meta-analysis. PROSPERO 2016 CRD42016042910. Available at: http://www.crd. york.ac.uk/PROSPERO/display-record.aspID=CRD42016042910. Accessed 24 August 2016
20. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015; 162:777-84
21. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-81
22. Higgins JP, Altman DG, Gøtzsche PC, et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343:d5928
23. Sterne JAC, Higgins JPT, Reeves BC; Development Group for ROBINS-I. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions, 5 July 2016. Available at: http://www.riskofbias.info. Accessed 24 August 2016
24. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-32
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60
27. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23:3105-24
28. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331:897-900
29. Cameron C, Fireman B, Hutton B, et al. Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities. Syst Rev 2015; 4:147
30. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med 2010; 29(7-8):932-44
31. Duncan EM, Cuthbertson BH, Prior ME, et al; SuDDICU International Study Group. The views of health care professionals about selective decontamination of the digestive tract: an international, theoretically informed interview study. J Crit Care 2014; 29:634-40
32. Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS One 2013; 8:e76654
33. Brun-Buisson C, Legrand P, Rauss A, et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 1989; 110:873-81
34. Champs CL, Guelon DP, Garnier RM, et al. Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit. Intensive Care Med 1993; 19:191-6
35. Peña C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998; 42:53-8
36. Corbella X, Montero A, Pujol M, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38:4086-95
37. D'Agata EM, Thayer V, Schaffner W. An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol 2000; 21:588-91
38. Lemmen SW, Häfner H, Kotterik S, Lütticken R, Töpper R. Influence of an infectious disease service on antibiotic prescription behavior and selection of multiresistant pathogens. Infection 2000; 28:384-7
39. Souweine B, Traore O, Aublet-Cuvelier B, et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 2000; 45:107-16
40. Agustí C, Pujol M, Argerich MJ, et al. Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. J Antimicrob Chemother 2002; 49:205-8
41. Parra Moreno ML, Arias Rivera S, López MA, et al. Effect of selective digestive decontamination on the nosocomial infection and multiresistant microorganisms incidence in critically ill patients [in Spanish]. Med Clin (Barc) 2002; 118:361-4
42. Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362:1011-6
43. Geissler A, Gerbeaux P, Granier I, Blanc P, Facon K, Durand-Gasselin J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med 2003; 29:49-54
44. Lee SO, Lee ES, Park SY, Kim SY, Seo YH, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25:832-7
45. Warren DK, Hill HA, Merz LR, et al. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant gram-negative bacteria among intensive care unit patients. Crit Care Med 2004; 32:2450-6
46. Troché G, Joly LM, Guibert M, Zazzo JF. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol 2005; 26:161-5
47. Borer A, Gilad J, Porat N, et al. Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect 2007; 67:149-55
48. Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect 2007; 65:354-60
49. Gould IM, MacKenzie FM, MacLennan G, Pacitti D, Watson EJ, Noble DW. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int J Antimicrob Agents 2007; 29:536-43
50. Apisarnthanarak A, Pinitchai U, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ; Thammasat University Pandrug-Resistant Acinetobacter baumannii Control Group. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008; 47:760-7
51. Laurent C, Rodriguez-Villalobos H, Rost F, et al. Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 2008; 29:517-24
52. Peto Z, Benko R, Matuz M, Csullog E, Molnar A, Hajdu E. Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in Hungary. Infection 2008; 36:560-4
53. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009; 30:447-52
54. Marra AR, Almeida SM, Correa L, et al. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control 2009; 37:204-9
55. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009; 30:959-63
56. Simón GMJ, González SJA, Alcudia PF, Sánchez SC, Gómez MB, Merino MMR. Evaluation of the effect of a cleaning/ disinfection intervention on the rate of multiresistant microorganism infections in the Intensive Care Unit [in Spanish]. Enferm Intensiva 2009; 20:27-34
57. Choi WS, Kim SH, Jeon EG, et al. Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program. J Korean Med Sci 2010; 25:999-1004
58. Nijssen S, Fluit A, van Vijver D, Top J, Willems R, Bonten MJ. Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria. Intensive Care Med 2010; 36:512-9
59. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Daily skin cleansing with chlorhexidine did not reduce the rate of central-line associated bloodstream infection in a surgical intensive care unit. Intensive Care Med 2010; 36:854-8
60. Prospero E, Barbadoro P, Esposto E, et al. Extended-spectrum beta-lactamases Klebsiella pneumoniae: multimodal infection control program in intensive care units. J Prev Med Hyg 2010; 51:110-5
61. Wen Z, Wei X, Xiao Y, et al. Intervention study of the association of antibiotic utilization measures with control of extended-spectrum beta-lactamase (ESBL)-producing bacteria. Microbes Infect 2010; 12:710-5
62. Smet AM, Kluytmans JA, Blok HE, et al. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis 2011; 11:372-80
63. Kim JW, Chung J, Choi SH, et al. Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial. Crit Care 2012; 16:R28
64. Montecalvo MA, McKenna D, Yarrish R, et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med 2012; 125:505-11
65. Nah SS, Park YH, Chung JW, et al. Acinetobacter baumannii infection was decreased by the structural renovation of a medical intensive care unit. J Crit Care 2013; 28:328-34
66. Schultsz C, Bootsma MC, Loan HT, et al. Effects of infection control measures on acquisition of five antimicrobial drug-resistant microorganisms in a tetanus intensive care unit in Vietnam. Intensive Care Med 2013; 39:661-71
67. Apisarnthanarak A, Pinitchai U, Warachan B, Warren DK, Khawcharoenporn T, Hayden MK. Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai intensive care unit: an analysis before and after extensive flooding. Am J Infect Control 2014; 42:116-21
68. Camus C, Salomon S, Bouchigny C, et al. Short-term decline in all-cause acquired infections with the routine use of a decontamination regimen combining topical polymyxin, tobramycin, and amphotericin B with mupirocin and chlorhexidine in the ICU: a single-center experience. Crit Care Med 2014; 42:1121-30
69. Derde LP, Cooper BS, Goossens H, et al; MOSAR WP3 Study Team. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014; 14:31-9
70. Enfield KB, Huq NN, Gosseling MF, et al. Control of simultaneous outbreaks of carbapenemase-producing Enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 Carbapenemase-Resistant Enterobacteriaceae Toolkit. Infect Control Hosp Epidemiol 2014; 35:810-7
71. Boyer A, Couallier V, Clouzeau B, et al. Control of extended-spectrum lactamase-producing Enterobacteriaceae nosocomial acquisition in an intensive care unit: a time series regression analysis. Am J Infect Control 2015; 43:1296-301
72. Chung YK, Kim JS, Lee SS, et al. Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity. Am J Infect Control 2015; 43:1171-7
73. Boonyasiri A, Thaisiam P, Permpikul C, et al. Effectiveness of chlorhexidine wipes for the prevention of multidrug-resistant bacterial colonization and hospital-acquired infections in intensive care unit patients: a randomized trial in Thailand. Infect Control Hosp Epidemiol 2016; 37:245-53
74. Bus L, Denys W, Catteeuw J, et al. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. Intensive Care Med 2016; 42:1029-39
75. Huang HP, Chen B, Wang HY, He M. The efficacy of daily chlorhexidine bathing for preventing healthcare-associated infections in adult intensive care units. Korean J Intern Med 2016;.31:1159-70
76. Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother 2016; 60:4840-52
77. Daneman N, Sarwar S, Fowler RA, Cuthbertson BH; SuDDICU Canadian Study Group. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13:328-41
78. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998; 36:1938-41
79. Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A. Risk of acquiring multidrug-resistant gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 2011; 17:1201-8
80. Husni RN, Goldstein LS, Arroliga AC, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999; 115:1378-82
81. Lee SO, Kim NJ, Choi SH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004; 48:224-8
82. Martínez JA, Aguilar J, Almela M, et al. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. J Antimicrob Chemother 2006; 58:1082-5
83. Nakamura A, Miyake K, Misawa S, et al. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect 2013; 83:153-5
84. Gómez-Zorrilla S, Camoez M, Tubau F, et al. Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Antimicrob Agents Chemother 2014; 58:5863-70
85. Price R, MacLennan G, Glen J; SuDDICU Collaboration. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 2014; 348:g2197
86. Decré D, Gachot B, Lucet JC, Arlet G, Bergogne-Bérézin E, Régnier B. Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 1998; 27:834-44
87. Lübbert C, Faucheux S, Becker-Rux D, et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents 2013; 42:565-70
88. Zaky A, Zeliadt SB, Treggiari MM. Patient-level interventions to prevent the acquisition of resistant gram-negative bacteria in critically ill patients: a systematic review. Anaesth Intensive Care 2015; 43:23-33